Mateusz Bilski, MD, PhD

Lublin Region Oncology Center

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 29

3231 - Development of Salvage Brachytherapy-Specific Genitourinary Toxicity Nomograms after Prostate Reirradiation

02:15pm - 03:30pm ET

Sep 29

3232 - Internally Validated Survival Nomograms for Recurrence, Metastasis, and Overall Survival after Salvage Prostate Brachytherapy

02:15pm - 03:30pm ET

Sep 29

3229 - PRO-BOOST-LC: Phase II/III Trial of Whole-Gland Boost Strategies vs. SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

02:15pm - 03:30pm ET

Sep 29

3230 - PRO-BOOST-N: Phase II/III Trial of Prostate-First vs. Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

02:15pm - 03:30pm ET

Sep 30

1220 - Salvage High-Dose-Rate Brachytherapy after Prior Prostate Radiotherapy: Contemporary Multi-Institutional Outcomes in 236 Patients

08:20am - 08:25am ET